Devi Jeyachandran, MD | |
Elm And Carlton St, Buffalo, NY 14263-6504 | |
(716) 845-2300 | |
Not Available |
Full Name | Devi Jeyachandran |
---|---|
Gender | Female |
Speciality | Pathology |
Experience | 17 Years |
Location | Elm And Carlton St, Buffalo, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184043960 | NPI | - | NPPES |
296677 | Other | NY | NYS LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0101X | Pathology - Anatomic Pathology | 296677 (New York) | Secondary |
207ZP0101X | Pathology - Anatomic Pathology | 25MA11731000 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Overlook Medical Center | Summit, NJ | Hospital |
Morristown Medical Center | Morristown, NJ | Hospital |
Chilton Medical Center | Pompton plains, NJ | Hospital |
Newton Medical Center | Newton, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Morristown Pathology Associates Pa | 4981699717 | 29 |
News Archive
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.
A new study from the Perelman School of Medicine at the University of Pennsylvania has found no significant difference in adjusted overall survival rates between gunshot and stabbing (so-called penetrating trauma injuries) victims in Philadelphia whether they were transported to the emergency department by the police department or the emergency medical services division of the fire department.
An exhibit highlighting the global health work of Seattle-area institutions is opening Tuesday in the Next 50 Plaza at Seattle Center, the Seattle Times reports.
Today, Humana Inc. announced an innovative Medicare Part D prescription drug plan, co-branded with Wal-Mart Stores, Inc., that can provide significant savings on monthly plan premiums and prescription medicine copayments and cost-shares for Medicare beneficiaries, including seniors and people with disabilities.
Sanaria Inc. and the PATH Malaria Vaccine Initiative has officially opened a one-of-a-kind clinical manufacturing facility to produce a vaccine that uses a weakened form of the malaria parasite to fight a disease that annually kills more than one million people, most of them African children.
› Verified 6 days ago
Entity Name | Morristown Pathology Associates Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922075886 PECOS PAC ID: 4981699717 Enrollment ID: O20040420000045 |
News Archive
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.
A new study from the Perelman School of Medicine at the University of Pennsylvania has found no significant difference in adjusted overall survival rates between gunshot and stabbing (so-called penetrating trauma injuries) victims in Philadelphia whether they were transported to the emergency department by the police department or the emergency medical services division of the fire department.
An exhibit highlighting the global health work of Seattle-area institutions is opening Tuesday in the Next 50 Plaza at Seattle Center, the Seattle Times reports.
Today, Humana Inc. announced an innovative Medicare Part D prescription drug plan, co-branded with Wal-Mart Stores, Inc., that can provide significant savings on monthly plan premiums and prescription medicine copayments and cost-shares for Medicare beneficiaries, including seniors and people with disabilities.
Sanaria Inc. and the PATH Malaria Vaccine Initiative has officially opened a one-of-a-kind clinical manufacturing facility to produce a vaccine that uses a weakened form of the malaria parasite to fight a disease that annually kills more than one million people, most of them African children.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Devi Jeyachandran, MD P.o. Box 500, Hackettstown, NJ 07840 Ph: (212) 241-8014 | Devi Jeyachandran, MD Elm And Carlton St, Buffalo, NY 14263-6504 Ph: (716) 845-2300 |
News Archive
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.
A new study from the Perelman School of Medicine at the University of Pennsylvania has found no significant difference in adjusted overall survival rates between gunshot and stabbing (so-called penetrating trauma injuries) victims in Philadelphia whether they were transported to the emergency department by the police department or the emergency medical services division of the fire department.
An exhibit highlighting the global health work of Seattle-area institutions is opening Tuesday in the Next 50 Plaza at Seattle Center, the Seattle Times reports.
Today, Humana Inc. announced an innovative Medicare Part D prescription drug plan, co-branded with Wal-Mart Stores, Inc., that can provide significant savings on monthly plan premiums and prescription medicine copayments and cost-shares for Medicare beneficiaries, including seniors and people with disabilities.
Sanaria Inc. and the PATH Malaria Vaccine Initiative has officially opened a one-of-a-kind clinical manufacturing facility to produce a vaccine that uses a weakened form of the malaria parasite to fight a disease that annually kills more than one million people, most of them African children.
› Verified 6 days ago
Young T Zhou, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2605 Harlem Rd, Buffalo, NY 14225 Phone: 716-891-2715 Fax: 716-529-3992 | |
Dr. Zhongbo Yang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton Streets, Buffalo, NY 14263 Phone: 716-845-2300 | |
Dr. Daniel Amsterdam, PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: 462 Grinder St, Erie County Medical Center, Buffalo, NY 14215 Phone: 716-898-3114 Fax: 716-898-3090 | |
Yousef Soofi, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 High St, Buffalo, NY 14203 Phone: 716-859-2259 | |
Dr. Leorosa Orendain Lehman, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 462 Grider St, Room L-169a, Buffalo, NY 14215 Phone: 716-898-3451 Fax: 716-898-4049 | |
Fadi Habib, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton St, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-3427 | |
Saraswati Pokharel, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton Streets, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-3427 |